TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | -3 | -2 | 3 | -2 | -13 | -11 | -4 |
| P | %wins | 0 | 50 | 50 | 50 | 50 | 0 | 33 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/29/08 13:21 | 8/27/08 | INFI | Infinity Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Holtzman Steven H | MA | DO | P,CEO | P | 164 | 7.40 | 0 | 22 | 9 | 257 | D | -46 | -29 | 2 | 4 | -1 | 2 | 1 | 1 | -4 | 0 | -7 | -15 | 4 | -6 |
9/18/07 08:54 | 9/14/07 | INFI | Infinity Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Holtzman Steven H | MA | DO | CB,CEO | P | 46 | 9.12 | 0 | 5 | 2 | 235 | D | -21 | -42 | -20 | -15 | -19 | -13 | -10 | -2 | -1 | -3 | 13 | 11 | -30 | -15 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |